Compare Aurobindo Pharma with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs J.B.CHEMICALS - Comparison Results

AUROBINDO PHARMA     Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA J.B.CHEMICALS AUROBINDO PHARMA/
J.B.CHEMICALS
 
P/E (TTM) x 14.2 16.4 86.5% View Chart
P/BV x 3.1 2.3 136.1% View Chart
Dividend Yield % 0.4 0.5 78.2%  

Financials

 AUROBINDO PHARMA   J.B.CHEMICALS
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-18
J.B.CHEMICALS
Mar-18
AUROBINDO PHARMA/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs809363 222.8%   
Low Rs504255 197.6%   
Sales per share (Unadj.) Rs281.1169.1 166.2%  
Earnings per share (Unadj.) Rs41.416.6 249.1%  
Cash flow per share (Unadj.) Rs50.923.4 217.3%  
Dividends per share (Unadj.) Rs2.502.00 125.0%  
Dividend yield (eoy) %0.40.6 58.8%  
Book value per share (Unadj.) Rs199.4172.5 115.6%  
Shares outstanding (eoy) m585.8883.57 701.1%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.31.8 127.8%   
Avg P/E ratio x15.918.6 85.3%  
P/CF ratio (eoy) x12.913.2 97.8%  
Price / Book Value ratio x3.31.8 183.8%  
Dividend payout %6.012.0 50.2%   
Avg Mkt Cap Rs m384,63025,827 1,489.2%   
No. of employees `00017.33.8 459.5%   
Total wages/salary Rs m21,3082,511 848.6%   
Avg. sales/employee Rs Th9,500.73,747.4 253.5%   
Avg. wages/employee Rs Th1,229.4665.7 184.7%   
Avg. net profit/employee Rs Th1,397.9367.8 380.1%   
INCOME DATA
Net Sales Rs m164,66614,135 1,164.9%  
Other income Rs m1,020366 278.8%   
Total revenues Rs m165,68614,501 1,142.6%   
Gross profit Rs m37,7182,178 1,731.5%  
Depreciation Rs m5,580570 979.4%   
Interest Rs m77735 2,226.9%   
Profit before tax Rs m32,3801,940 1,669.5%   
Minority Interest Rs m310-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m8,183552 1,481.6%   
Profit after tax Rs m24,2291,387 1,746.6%  
Gross profit margin %22.915.4 148.6%  
Effective tax rate %25.328.5 88.7%   
Net profit margin %14.79.8 149.9%  
BALANCE SHEET DATA
Current assets Rs m121,87810,470 1,164.1%   
Current liabilities Rs m86,8062,749 3,157.7%   
Net working cap to sales %21.354.6 39.0%  
Current ratio x1.43.8 36.9%  
Inventory Days Days13055 235.3%  
Debtors Days Days6878 88.0%  
Net fixed assets Rs m81,0375,811 1,394.5%   
Share capital Rs m586167 350.6%   
"Free" reserves Rs m116,21814,248 815.7%   
Net worth Rs m116,80414,416 810.3%   
Long term debt Rs m4,5120-   
Total assets Rs m211,05217,649 1,195.8%  
Interest coverage x42.756.6 75.4%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.8 97.4%   
Return on assets %11.88.1 147.0%  
Return on equity %20.79.6 215.6%  
Return on capital %27.413.7 199.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m80,7276,164 1,309.7%   
Fx outflow Rs m34,7001,334 2,600.4%   
Net fx Rs m46,0274,829 953.0%   
CASH FLOW
From Operations Rs m19,5481,231 1,588.6%  
From Investments Rs m-19,570-208 9,403.9%  
From Financial Activity Rs m8,642-595 -1,451.9%  
Net Cashflow Rs m8,922427 2,089.0%  

Share Holding

Indian Promoters % 54.1 55.4 97.7%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 8.0 3.4 234.5%  
FIIs % 27.7 3.9 710.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.2 37.0 27.6%  
Shareholders   69,601 30,437 228.7%  
Pledged promoter(s) holding % 8.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   ORCHID PHARMA LTD  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  DR. REDDYS LAB  

Compare AUROBINDO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Climbs 975 Points Up; FMCG Stocks Fuel the Rally(09:30 am)

Asian share markets started higher on Monday on hopes of an interim Sino-US tariff deal after the two countries described their talks as "productive" and "constructive".

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 38.6% YoY). Sales on the other hand came in at Rs 54 bn (up 28.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 10.9% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 10.9% YoY). Sales on the other hand came in at Rs 53 bn (up 30.7% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

AUROBINDO PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 19.3% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (up 19.3% YoY). Sales on the other hand came in at Rs 53 bn (up 21.5% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

My 7 Stocks to Buy Are Companies Which Will Be a Big Part of New India(The 5 Minute Wrapup)

Sep 19, 2019

The India we knew is changing. Here's how you can benefit from this change.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

Did the Tax Bonanza Really Deserve a 2,000-point Gain on the Sensex?(Profit Hunter)

Sep 20, 2019

Are investors overdoing their euphoria post the corporate tax cut bonanza?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Sep 23, 2019 12:11 PM

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS